Article

ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eye

Author(s):

Alex Delaney-Gesing
Conferences|ASCRS

Sanjay N. Rao, MD, director of Refractive, Cornea and Advanced Anterior Segment Surgery at Dekalb Eye Consultants LLC, speaks with Ophthalmology Times' David Hutton on his presentation "Evaluation of intraoperative use of dexamethasone intraocular suspension, 9% (DEXYCU) on signs and symptoms of dry eye," during the 2020 ASCRS virtual conference.

 

See more ASCRS coverage here 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) meeting, Seth Pantanelli, MD, speaks about the EyHance and enVista IOLs. Dr. Pantanelli is a professor of ophthalmology at Penn State College of Medicine in Hershey, Pennsylvania.
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
Related Content
Sight Sciences releases cost-utility analysis comparing TearCare and cyclosporine 0.05% in dry eye
August 5th 2025

Sight Sciences releases cost-utility analysis comparing TearCare and cyclosporine 0.05% in dry eye

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)
August 5th 2025

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

Raytone Biotech treats first patient in clinical trial of RTP-008 for dry eye disease
August 5th 2025

Raytone Biotech treats first patient in clinical trial of RTP-008 for dry eye disease

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)
August 5th 2025

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

New RainDrop Dispenser Aid aims to simplify use of single-use eye drops
August 5th 2025

New RainDrop Dispenser Aid aims to simplify use of single-use eye drops

Precautionary recall announced for specific batch of Zaditen eye drops in the UK
August 5th 2025

Precautionary recall announced for specific batch of Zaditen eye drops in the UK

© 2025 MJH Life Sciences

All rights reserved.